Clinical Trials Browser

Lymphoma, B-Cell × Interleukin 1 Receptor Antagonist Protein × Clear all

NCT04148430 2025-11-05

A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy

Phase 2 Active not recruiting

Burkitt Lymphoma, Lymphoma, B-Cell

NCT04359784 2025-10-23

Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy

Phase 2 Completed

27 enrolled 15 charts

Lymphoma, B-Cell